Zobrazeno 1 - 10
of 320
pro vyhledávání: '"Fenghua, Meng"'
Autor:
Yifeng Xia, Jingnan An, Jiaying Li, Wenxing Gu, Yifan Zhang, Songsong Zhao, Cenzhu Zhao, Yang Xu, Bin Li, Zhiyuan Zhong, Fenghua Meng
Publikováno v:
Bioactive Materials, Vol 31, Iss , Pp 312-314 (2024)
Externí odkaz:
https://doaj.org/article/5c1b49a326714e9c949762066c4764d3
Autor:
Beibei Guo, Yan Qu, Yinping Sun, Songsong Zhao, Jiandong Yuan, Peizhuo Zhang, Zhiyuan Zhong, Fenghua Meng
Publikováno v:
Bioactive Materials, Vol 25, Iss , Pp 61-72 (2023)
Triple-negative breast cancer (TNBC) due to lack of clear target and notorious “cold” tumor microenvironment (TME) is one of the most intractable and lethal malignancies. Tuning “cold” TME into “hot” becomes an emerging therapeutic strate
Externí odkaz:
https://doaj.org/article/afd6d4b7d3244d679c655fcb902854fd
Autor:
Yifeng Xia, Jingnan An, Jiaying Li, Wenxing Gu, Yifan Zhang, Songsong Zhao, Cenzhu Zhao, Yang Xu, Bin Li, Zhiyuan Zhong, Fenghua Meng
Publikováno v:
Bioactive Materials, Vol 21, Iss , Pp 499-510 (2023)
Acute myeloid leukemia (AML) remains a most lethal hematological malignancy, partly because of its slow development of targeted therapies compared with other cancers. PLK1 inhibitor, volasertib (Vol), is among the few molecular targeted drugs granted
Externí odkaz:
https://doaj.org/article/0fb087f5dd764d218061cea5e412d265
Autor:
Huan Zheng, Beibei Guo, Xinyun Qiu, Yifeng Xia, Yan Qu, Liang Cheng, Fenghua Meng, Zhiyuan Zhong
Publikováno v:
Bioactive Materials, Vol 16, Iss , Pp 1-11 (2022)
Cyclic dinucleotides (CDNs) as stimulator of interferon genes (STING) agonists capable of inducing strong antitumor innate immune response are highly promising for tumor immunotherapy. The efficacy of these CDNs is, however, reduced greatly by their
Externí odkaz:
https://doaj.org/article/4a1756f79f7b40ad808effe5ad579f31
Autor:
Lu Diao, Lin Ma, Junping Cheng, Yunzhi Pan, Zuofu Peng, Lianjun Zhang, Minghao Xu, Yupei Li, Xuenong Zhang, Honglv Jiang, Guoqiang Xu, Fenghua Meng, Zhiyuan Zhong, Mi Liu
Publikováno v:
iScience, Vol 25, Iss 12, Pp 105511- (2022)
Summary: Metastatic cancers and recurrent cancers are diverse, different from primary cancers, and organ-dependent. However, how strong are across-cancer immune responses among different types of cancers remain unclear. Herein, vaccines-encapsulated-
Externí odkaz:
https://doaj.org/article/552d9e655544420fb8c58cb4aea7cba3
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/7d5a1ff77d044e1bb9789bf91343862c
Autor:
Zhehong Zhu, Manran Wu, Juan Sun, Zhengyuan Huangfu, Lingling Yin, Weipeng Yong, Jing Sun, Guanglin Wang, Fenghua Meng, Zhiyuan Zhong
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 2301-2309 (2021)
Radiotherapy (RT) is a frequently used means in clinical tumor treatment. The outcome of RT varies, however, to a great extent, due to RT resistance or intolerable dose, which might be resolved by the development of radio-sensitizing strategies. Here
Externí odkaz:
https://doaj.org/article/7ab1bdf9134343d89b77a5cfc268abef
Autor:
Jingjing Wei, Di Wu, Songsong Zhao, Yu Shao, Yifeng Xia, Dawei Ni, Xinyun Qiu, Jinping Zhang, Jian Chen, Fenghua Meng, Zhiyuan Zhong
Publikováno v:
Advanced Science, Vol 9, Iss 13, Pp n/a-n/a (2022)
Abstract Immunotherapy with toll like receptor 9 (TLR9) agonist CpG ODN offers an emergent strategy to treat life‐threatening malignant glioma. CpG is typically applied invasively by intracranial and intrathecal administration which induces not onl
Externí odkaz:
https://doaj.org/article/eedcca30536b4088aeac076fb038947e
Autor:
Liang Yang, Yongjie Sha, Yuansong Wei, Hanghang Fang, Jingjing Jiang, Lichen Yin, Zhiyuan Zhong, Fenghua Meng
Publikováno v:
Biomaterials Science. 11:2211-2220
Inflammation targeted delivery of methotrexate using mannose-installed polymersomes (Man-PMTX) can repolarize macrophages from M1 type to M2 type and mitigate proinflammatory cytokines, leading to effectively augmented rheumatoid arthritis therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca028c92bb57b4c18194c01bd5f91ee8
https://doi.org/10.1039/d2bm02072f
https://doi.org/10.1039/d2bm02072f
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1482-1490 (2017)
The chemotherapy of hematological cancers is challenged by its poor selectivity that leads to low therapeutic efficacy and pronounced adverse effects. Here, we report that doxorubicin encapsulated in lipoic acid-crosslinked hyaluronic acid nanopartic
Externí odkaz:
https://doaj.org/article/1555d2b4958249089b06f242de3740ca